ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

What Would You Tell a 45-Year-Old? Waxman Asks Broder

February 4, 1994

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

DCPC Advisors Request New Study Section In Prevention And Control Of Chronic Disease

July 30, 1993

NTP Committee Accepts Industry Positions On Policy To Separate Figures for Benign, Malignant Lesions

November 7, 1980

NCI Programs: Pediatric Brain Tumor Grants Awarded

April 16, 1999

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012